Salvianolic Acid B Inhibits LH2-Driven Collagen Synthesis in
2026-06-17
This study elucidates how Salvianolic acid B (Dan Shen Suan B) directly inhibits lysyl hydroxylase 2 (LH2), disrupting collagen cross-linking and extracellular matrix remodeling in pulmonary fibrosis models. The findings highlight a molecularly targeted, natural approach to antifibrotic intervention, with practical implications for fibrosis research.
SD 169 (indole-5-carboxamide): Beyond Inhibition—Novel Mecha
2026-06-16
Discover how SD 169 (indole-5-carboxamide) enables advanced control of p38 MAPK signaling through dual-action inhibition and activation loop dephosphorylation. This in-depth analysis reveals new mechanistic insights and assay strategies vital for type 1 diabetes and axonal regeneration research.
Resolving RNA Synthesis Challenges with T7 RNA Polymerase (K
2026-06-16
This article delivers a scenario-driven, evidence-based guide for biomedical researchers and lab technicians addressing common bottlenecks in RNA synthesis, transfection, and workflow reproducibility. Through five real-world Q&A blocks and data-backed analysis, it demonstrates how T7 RNA Polymerase (SKU K1083)—a recombinant enzyme expressed in E. coli—delivers robust, high-fidelity results for in vitro transcription, RNA vaccine production, and advanced RNAi studies.
Everolimus (RAD001): Applied mTOR Inhibition in Cancer Resea
2026-06-15
Everolimus (RAD001) empowers researchers to dissect mTOR pathway inhibition with precision, enabling robust apoptosis and proliferation studies in cancer models. This guide details optimized workflows, troubleshooting, and insights drawn from cutting-edge reference studies to elevate experimental outcomes.
Photodynamic Targeting of Dental Biofilms with Liposomal p-T
2026-06-15
Liang et al. present a novel liposome-encapsulated, blue light-activated p-toluquinone system for precise eradication of multispecies dental biofilms. Their approach demonstrates targeted delivery, pH-responsive selectivity, and strong antimicrobial efficacy, offering a promising alternative to traditional oral infection management.
Comparative In Vitro Activity of Temafloxacin vs. Quinolones
2026-06-14
The reference study systematically compares the in vitro potency of temafloxacin, ciprofloxacin, and ofloxacin against a broad panel of Gram-negative pathogens. Key findings reveal temafloxacin's notably low MICs for respiratory and enteric bacteria, underscoring the evolution of quinolone antibiotics and informing future experimental choices in antimicrobial research.
Nonivamide (Capsaicin Analog): Advanced Workflows in Cancer
2026-06-13
Nonivamide, a potent capsaicin analog, offers selective TRPV1 activation for precise modeling of cancer cell apoptosis and neuroimmune pathways. This guide delivers actionable workflows, troubleshooting insights, and unique use-case differentiation, enabling researchers to harness Nonivamide’s full experimental potential.
Primidone (Mysoline): Translational Advances in TRPM3 & RIPK
2026-06-12
Primidone (Mysoline) is redefining translational research as a dual TRPM3 and RIPK1 inhibitor, with validated impact in neurodegenerative and gynecological disease models. Learn how robust protocols and troubleshooting tips can optimize your experimental outcomes using APExBIO’s high-purity Primidone.
SAG Mitigates Mitochondrial Dysfunction in Frataxin-Deficien
2026-06-12
Vicente-Acosta et al. (2022) demonstrate that pharmacological activation of the Hedgehog pathway with the Smoothened agonist SAG rescues mitochondrial function and reduces neurotoxicity in frataxin-deficient human astrocytes, a cellular model of Friedreich’s ataxia. Their work highlights the potential of Hedgehog pathway modulation as a neuroprotective strategy in rare neurodegenerative disease contexts.
Cy3 NHS ester (non-sulfonated): Technical Guide for Biomolec
2026-06-11
Cy3 NHS ester (non-sulfonated) provides a reliable solution for fluorescent labeling of proteins, peptides, and oligonucleotides by targeting primary amines. It is well-suited for workflows that tolerate organic co-solvents, but is not recommended for delicate proteins or strictly aqueous protocols. Researchers can achieve sensitive detection in imaging and analytical assays when following solvent and storage best practices.
(S)-Mephenytoin: CYP2C19 Substrate for Organoid Drug Metabol
2026-06-11
(S)-Mephenytoin, the gold-standard CYP2C19 substrate, empowers precise oxidative drug metabolism studies in advanced human intestinal organoid models. Leveraging its robust kinetic performance, researchers can overcome the limitations of traditional systems and achieve translationally relevant pharmacokinetic insights. APExBIO’s high-purity (S)-Mephenytoin streamlines assay reproducibility, supporting the next generation of in vitro pharmacokinetic research.
CD28-ARS2 Axis Controls PKM2 Splicing for T Cell Antitumor I
2026-06-10
This study reveals that CD28-ARS2 signaling in CD8+ T cells drives alternative splicing of pyruvate kinase (PKM), favoring the PKM2 isoform, which is essential for metabolic flexibility and robust antitumor immunity. The findings provide mechanistic insight into how T cell metabolic programming is post-transcriptionally regulated, offering new perspectives for immunometabolic intervention strategies.
Cy5 Hydrazide in Quantitative Carbonylation Analysis & Food-
2026-06-10
Explore how Cy5 hydrazide, a carbonyl-reactive fluorescent dye, empowers quantitative biomolecule labeling and advances food-grade nanotechnology. This article offers deep protocol guidance and integrates the latest research on FAST-enabled nanoparticle imaging.
Comparative Antibacterial Activity of Cefoperazone and New β
2026-06-09
The reference study systematically compared N-formimidoyl thienamycin (MK0787) to several recently developed β-lactam antibiotics, including cefoperazone, across a diverse set of multidrug-resistant clinical isolates. Its findings clarify the nuanced activity spectrum of cefoperazone sodium salt and reinforce its value in research on gram-negative resistance and β-lactamase stability.
HOXC8 Suppresses Pyroptosis in NSCLC via Caspase-1 Regulatio
2026-06-09
The referenced study reveals that HOXC8, a homeobox transcription factor, prevents pyroptotic cell death in non-small cell lung carcinoma (NSCLC) by repressing caspase-1 expression through recruitment of HDAC1/2 to the CASP1 promoter. These findings clarify a key regulatory axis in lung tumorigenesis and identify potential targets for modulating cell death and inflammatory signaling in cancer.
461 records 15/31 page Previous Next First page 上5页 1112131415 下5页 Last page